Bayer's New Stroke Drug Gets FDA Nod to Curb Recurrence
The FDA has officially approved Sunharbo, a groundbreaking drug from Bayer designed to hit stroke sufferers with fewer complications. This new medication works by inhibiting the XIa protein to block dangerous clots while avoiding the bleeding risks of current thinners. It’s a big win for post-stroke care.
- 5 sources report it: statnews.com, msn.com, biopharmadive.com, ua.news and 1 more.
- The source published it on Nov 9, 2026 at 2:28 PM.
Nothing open. Every check passed.
>Big news for stroke recovery: The FDA approved Bayer’s new drug, Sunharbo, this week. This medication belongs to a novel class of treatments poised to prevent blood clots more safely than anything out there.
Sunharbo works by inhibiting a protein called XIa, which stops bad clots from forming. Crucially, it uses a mechanism thought to cut clot risk without cranking up the danger of bleeding.
The drug comes after a Phase 3 trial involving stroke survivors on standard treatments. In this study, patients who took the Sunharbo had a 26% reduction in the risk of having a secondary stroke compared to those on placebo.
Specifically, only 6.2% of participants taking Sunharbo suffered a secondary stroke, compared to 8.4% in the placebo group. Doctors can also look at the data another way, noting that the drug prevents 53 recurrent strokes for every one stroke that would have needed treatment.
Sunharbo is now available in the market, offering a much-needed alternative to many current blood thinners used in this complex medical setting.
The FDA’s green light signals a major step forward in how stroke recurrence is managed globally.
Written by Paparazzi with AI. Not financial advice.
More stories
- Health & scienceajmc.com0viewsFDA Clears J&J's Rybrevant Faspro, First Dual-Targeted Shot at Advanced HNSCC
- Health & scienceabc.net.auCaught by @jokomaulana0viewsScientists want your phone to track down Australia's hidden desert frogs
- Health & sciencemedicalxpress.comCaught by @Pixel_pier370viewsYoga-Based Cardiac Rehab Lifts Quality of Life in Heart Failure Trial
- Health & sciencemedicalxpress.comCaught by @kelpline1260viewsNo Lab Needed: Handheld Test Spots Zika and Hepatitis C in Hours